Main Sequence

Main Sequence is an independently managed deep-tech venture firm that creates and invests in companies built around scientific research.

Official website

AI and deep-technology venture capital investor
AI & Deep Tech Venture Capital
Tier II

Overview

Main Sequence is an independently managed deep-tech venture firm that creates and invests in companies built around scientific research. Founded with Australia’s national science agency CSIRO, it supports businesses from seed through Series B across space, climate, food and agriculture, healthcare, industrial productivity, and the next generation of intelligence.

The platform is designed to bridge the commercialization gap between public research and global company formation. It combines capital with scientific networks, laboratories, industry relationships, and hands-on support, while its later funds have attracted substantial private institutional capital. Within The Economy Wiki, the institution is connected to the AI & Deep Tech Venture Capital market category.

Firm facts

Institution	Main Sequence
Type	AI and deep-technology venture capital investor
Headquarters	Sydney, Australia
Founded	2017
Primary ranking focus	AI & Deep Tech Venture Capital
Highest 2026 tier	Tier II

Contents

Activities and investment capabilities
Strategy and market coverage
Market position
Competitive context
Leadership and governance
Corporate and public information
Ranking recognition
Related Economy analysis
Related institutions and subjects
Sources

Activities and investment capabilities

Main Sequence operates within artificial intelligence, scientific computing and technically complex company formation. Its category-specific capabilities are summarized below.

Technical investing

Evaluation of research, engineering architectures and defensible technical capabilities.

Deep-tech formation

Capital for businesses that must prove scientific or industrial feasibility before scale.

Commercial translation

Support connecting technical teams with customers, talent, policy and later capital.

Strategy and market coverage

Stage and strategy coverage

Pre-seed through growth; research commercialization; technical company formation

Sector and market coverage

AI; robotics; computing; semiconductors; biotechnology; defense; space and advanced industry

Market position

Main Sequence fits Tier II because it is the strongest institutional representative of Australia’s deep-tech commercialization ecosystem. Its public-research origins do not diminish its independently managed venture model; instead, they provide differentiated access to technical invention and infrastructure.

Main Sequence is assessed within the AI & Deep Tech Venture Capital framework. For wider market context, see Private Equity Technology Due Diligence in the AI Era.

Competitive context

Main Sequence is recognized Tier II in Top 30 AI & Deep Tech Venture Capital 2026. The rankings compare institutions by market relevance, investment or operating capability, sector and stage expertise, institutional credibility and current activity. Comparable links support navigation and do not imply that every institution competes for every company, fund commitment or transaction.

Leadership and governance

Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through the institution’s official website.

Leadership area	Current source
Investment and operating leadership	Current team and governance information

Corporate and public information

This profile refers to Main Sequence as the public-facing organization. Individual funds, management companies, advisers, lending entities, broker-dealers and regulated affiliates may use separate legal names across jurisdictions.

Corporate and disclosure information

Organization	Main Sequence
Headquarters	Sydney, Australia
Public website	www.mseq.vc
Profile basis	Public institutional information and Capital Ranking editorial research